Vasomedical, Inc.

Website Links

Description

Vasomedical Global Corp. (VasoGlobal), a wholly-owned subsidiary of Vasomedical Inc. was established to manage the operations of the Company’s operating subsidiaries in China and identify and manage potential accretive acquisitions the Company may consider. Some of the operations VasoGlobal manages are the establishment and managing of sales channels, product development, marketing of innovative, low cost technologies, regulatory clearances, OEM partnerships and manufacturing.

Biox Instruments Co., Ltd., a wholly owned subsidiary of Vasomedical, is based in Wuxi, Jiangsu Province, China. With long established expertise in miniaturization and low power consumption medical devices, it is a leading company in ambulatory monitoring systems consisting of ECG Holter recorders, ambulatory blood pressure monitoring (ABPM) systems as well as related analysis and reporting software. Biox is in full compliance of revered quality and manufacturing standards such as ISO 13485, ISO 9001, US FDA cGMP as well as the Medical Device Directive of the European Union.

Dave joined the Vasomedical team in January 2013 with an extensive background and proven track record in healthcare sales and service management. With over 30 years of experience with Xerox, Pfizer Medical Systems and Siemens Medical Solutions Dave has gained significant experience handling the challenges and responsibilities of management in a number of senior positions including District Manager, Zone and Regional Vice President, as well as Manager and Senior Director of Strategic National Accounts.

About LET Life Enhancement Technologies (LET), based in Foshan, Guangdong, China, has been a technology and alternate manufacturing source for Vasomedical’s proprietary Enhanced External Counterpulsation (EECP ® ) Therapy systems, including certain Lumenair™ systems and all AngioNew ® systems for over 15 years.

Fact sheet

Company contacts

Companies nearby